SPECIAL FEATURE| Volume 355, ISSUE 5, P510-514, May 2018

May-Thurner Syndrome

Published:October 17, 2017DOI:


      This single-center, retrospective review identified 6 patients (n = 6, 100% female) treated by endovascular therapy for May-Thurner syndrome from June 2013 to September 2015. Patients consisted of 3 African American, 2 Caucasian and 1 Asian; mean age was 53.50 ± 8.31 years, range: 39-63 years. Clinical presentations consisted of left lower extremity deep vein thrombosis in 4, left lower extremity deep vein thrombosis with pulmonary embolism in 1 and pulmonary embolism with left common iliac vein thrombosis in 1 patient. All 6 patients were treated with catheter‐directed thrombolysis and venous stenting to correct the underlying anatomical defect. Hypercoagulability work up revealed antiphospholipid antibody syndrome in 1 patient. No major periprocedural complications were observed. Median follow-up period was 22 ± 5.5 months (range: 13-30 months). One patient with pre-exiting antiphospholipid antibody syndrome developed stent thrombosis with secondary loss of patency. Endovascular therapy for May-Thurner syndrome in our adult cohort seemed safe and effective. One patient with pre-existing thrombophilia developed secondary loss of stent patency, suggesting need for further investigation in this subgroup.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • May R.
        • Thurner J.
        The cause of the predominantly sinister occurrence of thrombosis of the pelvic veins.
        Angiology. 1957; 8: 419-427
        • Kibbe M.R.
        • Ujiki M.
        • Goodwin A.L.
        • et al.
        Iliac vein compression in an asymptomatic patient population.
        J Vasc Surg. 2004; 39: 937-943
        • Kearon C.
        • Akl E.A.
        • Ornelas J.
        • et al.
        Antithrombotic therapy for VTE disease.
        Chest. 2016; 149: 315-352
        • Og˘uzkurt L.
        • Ozkan U.
        • Tercan F.
        • et al.
        Ultrasonographic diagnosis of iliac vein compression (May-Thurner) syndrome.
        Diagn Interv Radiol. 2007; 13: 152-155
        • Lamba R.
        • Tanner D.T.
        • Sekhon S.
        • et al.
        Multidetector CT of vascular compression syndromes in the abdomen and pelvis.
        Radiographics. 2014; 34: 93-115
        • Butros S.R.
        • Liu R.
        • Oliveira G.R.
        • et al.
        Venous compression syndromes: clinical features, imaging findings and management.
        Br J Radiol. 2013; 86 (20130284)
        • Jeraj L.
        • Jezovnik M.K.
        • Poredos P.
        Insufficient recanalization of thrombotic venous occlusion—risk for postthrombotic syndrome.
        J Vasc Interv Radiol. 2017; 28: 941-944
        • Suwanabol P.A.
        • Tefera G.
        • Schwarze M.L.
        Syndromes associated with the deep veins: phlegmasia cerulea dolens, May-Thurner syndrome, and nutcracker syndrome.
        Perspect Vasc Surg Endovasc Ther. 2010; 22: 223-230
        • Hosn M.A.
        • Katragunta N.
        • Kresowik T.
        • et al.
        May-Thurner syndrome presenting as spontaneous left iliac vein rupture.
        J Vasc Surg Venous Lymphat Disord. 2016; 4: 479-481
        • Eliahou R.
        • Sosna J.
        • Bloom A.I.
        Between a rock and a hard place: clinical and imaging features of vascular compression syndromes.
        Radiographics. 2012; 32: E33-E49
        • Cockett F.B.
        • Thomas M.L.
        The iliac compression syndrome.
        Br J Surg. 1965; 52: 816-821
        • Lamont J.P.
        • Pearl G.J.
        • Patetsios P.
        • et al.
        Prospective evaluation of endoluminal venous stents in the treatment of the May-Thurner syndrome.
        Ann Vasc Surg. 2002; 16: 61-64
        • Patel N.H.
        • Stookey K.R.
        • Ketcham D.B.
        • et al.
        Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome.
        J Vasc Interv Radiol. 2000; 11: 1297-1302
        • Titus J.M.
        • Moise M.A.
        • Bena J.
        • et al.
        Iliofemoral stenting for venous occlusive disease.
        J Vasc Surg. 2011; 53: 706-712
        • Meissner M.H.
        • Manzo R.A.
        • Bergelin R.O.
        • et al.
        Deep venous insufficiency: the relationship between lysis and subsequent reflux.
        J Vasc Surg. 1993; 18 ([discussion 606-8]): 596-605
        • Meissner M.H.
        Indications for platelet aggregation inhibitors after venous stents.
        Phlebology. 2013; 28: S91-S98
        • Villalta S.
        • Bagatella P.
        • Piccioli A.
        • et al.
        Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome.
        Haemostasis. 1994; 24: 158